Trials / Completed
CompletedNCT01228175
Effectiveness of Varenicline: Testing Individual Differences
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 218 (actual)
- Sponsor
- The Mind Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | 25mg look alike riboflavin tablets to match active study medication. |
| DRUG | Varenicline | Days 1-3 - .5mg tablet 1xdaily Days 4-7 - .5mg tablet 2xdaily Days 8-84 - 1mg tablet 2xdaily |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2015-02-01
- Completion
- 2016-03-01
- First posted
- 2010-10-26
- Last updated
- 2018-05-09
- Results posted
- 2016-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01228175. Inclusion in this directory is not an endorsement.